@DrMeenaRafiq presents that there are changes in clinical presentation, signs, blood test requests and abnormalities and prescriptions In @BJGPjournal https://t.co/AHj21AensQ https://t.co/9uBJPM7Ait https://t.co/jAwth43OFw
RT @BJGPjournal: Hodgkin lymphoma: several months pre-diagnosis, increases in inflammatory marker requests and abnormal results occur in ma…
RT @BJGPjournal: Hodgkin lymphoma: several months pre-diagnosis, increases in inflammatory marker requests and abnormal results occur in ma…
RT @BJGPjournal: Hodgkin lymphoma: several months pre-diagnosis, increases in inflammatory marker requests and abnormal results occur in ma…
Hodgkin lymphoma: several months pre-diagnosis, increases in inflammatory marker requests and abnormal results occur in many patients with #HodgkinLymphoma ☞ https://t.co/oF5sG1zClh @DrMeenaRafiq @garyabel @Glyratzopoulos @UCL_BSH @RMPartnersNHS https://
RT @BJGPjournal: Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, an…
RT @BJGPjournal: Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, an…
RT @BJGPjournal: Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, an…
Congrats @DrMeenaRafiq on your publication!! The DGP is proud of you! 🎉
RT @BJGPjournal: Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, an…
RT @BJGPjournal: Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, an…
RT @BJGPjournal: Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, an…
RT @BJGPjournal: Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, an…
Several months before Hodgkin lymphoma diagnosis, increases have been found in inflammatory marker blood test requests, and abnormal results https://t.co/oF5sG1zClh @DrMeenaRafiq @garyabel @Glyratzopoulos @UCL_BSH @RMPartnersNHS #HodgkinLymphoma Watch the
Open Access UCL Research: Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years https://t.co/9GV11F4QQP
RT @BJGPjournal: Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis Video and podcast interview out…
RT @DrMeenaRafiq: Our @BJGP paper shows: ✅In Hodgkin lymphoma (HL) patients GP inflammatory marker(IM) use ⬆️in the year pre-diagnosis ✅A t…
RT @DrMeenaRafiq: Our @BJGP paper shows: ✅In Hodgkin lymphoma (HL) patients GP inflammatory marker(IM) use ⬆️in the year pre-diagnosis ✅A t…
RT @DrMeenaRafiq: Our @BJGP paper shows: ✅In Hodgkin lymphoma (HL) patients GP inflammatory marker(IM) use ⬆️in the year pre-diagnosis ✅A t…
Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis Video and podcast interview out next week.
RT @UEMSHealthStats: Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-…
RT @DrMeenaRafiq: Our @BJGP paper shows: ✅In Hodgkin lymphoma (HL) patients GP inflammatory marker(IM) use ⬆️in the year pre-diagnosis ✅A t…
RT @GLyratzopoulos: 1/n Led by our colleague @DrMeenaRafiq , @BJGPjournal paper (w' @garyabel & Cristina Renzi) documenting 'diagnostic win…
2/n For anyone new to the diagnostic window concept / evidence in cancer patients, we have recently collated the global literature in a @CancerEpid review led by colleague @BexKWhite https://t.co/KSQL5sy4vH https://t.co/WCZCv48BzY
1/n Led by our colleague @DrMeenaRafiq , @BJGPjournal paper (w' @garyabel & Cristina Renzi) documenting 'diagnostic windows' of appreciable length in Hodgkin lymphoma, defined by inflammatory marker tests https://t.co/EMVZKgxK2C https://t.co/cOUTsVbKaP
Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years. https://t.co/IF2PDCVOeR #healthstatistics @UofE_Research @ExeterMed @garyabel @UoEAPEx @BJGPjour
RT @DrMeenaRafiq: Our @BJGP paper shows: ✅In Hodgkin lymphoma (HL) patients GP inflammatory marker(IM) use ⬆️in the year pre-diagnosis ✅A t…
Our @BJGP paper shows: ✅In Hodgkin lymphoma (HL) patients GP inflammatory marker(IM) use ⬆️in the year pre-diagnosis ✅A time window exists for earlier diagnosis ✅Abnormal IMs can be early signs of HL and often occur in patients without red flag symptoms ht
Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years #lymphoma #lymsm https://t.co/iSRmOyxS2g
RT @BJGPjournal: Hodgkin lymphoma: increases in inflammatory marker requests and abnormal results occur in many patients with Hodgkin lymph…
RT @BJGPjournal: Hodgkin lymphoma: increases in inflammatory marker requests and abnormal results occur in many patients with Hodgkin lymph…
Hodgkin lymphoma: increases in inflammatory marker requests and abnormal results occur in many patients with Hodgkin lymphoma pre-diagnosis Figure X-axis = months pre-diagnosis/index date https://t.co/oF5sG1zClh @DrMeenaRafiq @garyabel @Glyratzopoulos @U
Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years https://t.co/w5Y1fcsLdi